DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

CUSIP: 253748206

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
4,072,011
Share change
+213,307
Total reported value
$1,758,000
Price per share
$0.43
Number of holders
16
Value change
+$88,882
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 253748206?
CUSIP 253748206 identifies DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) as of Q3 2018

As of 30 Sep 2018, DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,072,011 shares. The largest 10 holders included Swift Run Capital Management, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, TWO SIGMA SECURITIES, LLC, Virtu Financial LLC, UBS Group AG, NORTHERN TRUST CORP, and JANE STREET GROUP, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.